HIGHFDA DRUG

MediNatura Recalls ReBoost Nasal Spray Due to Microbial Contamination

MediNatura recalled ReBoost Nasal Spray on December 12, 2025, due to microbial contamination. The affected product, distributed nationwide, contains yeast/mold and Achromobacter. Consumers should stop using the product immediately.

Official notice

Source-backed recall notice

No product image was available from the source feed.

Official source
FDA DRUG
Recall date
December 12, 2025
Status
ACTIVE
Severity
8/10

Quick Facts at a Glance

Recall Date
December 12, 2025
Hazard Level
HIGH
Brands
ReBoost, MediNatura
Category
Health & Personal Care
Sold At
Multiple Retailers
Geographic Scope
1 states
At-Risk Groups
GENERAL

What to Do Now

Use this page like a recall checklist: verify the product first, then act on the official remedy.

Immediate steps

  1. 1Stop using the product until you confirm whether it is included in the recall.
  2. 2Compare the product label, model number, UPC, color, size, and purchase location against the identifiers below.
  3. 3Follow the official remedy from FDA - Drug Safety; save photos, receipts, labels, and correspondence before contacting the company.
  4. 4If the product could harm a child, older adult, pet, or patient, move it out of reach immediately.

Check these identifiers

Brand
ReBoost, MediNatura
Product type
Nasal Spray
Model numbers
All lots within expiry.
UPC codes
62795-4005, 62795-4005-9, 7876471018
Sold at
Multiple Retailers
Where affected
ALL

Recall Timeline

Key dates and source checks for this recall record.

  1. Recall announced

    December 12, 2025

  2. Reported by FDA DRUG

    January 14, 2026

  3. RecallRadar source check

    January 21, 2026

  4. Consumer action

    Use the official remedy and keep documentation.

Hazard Information

Microbial Contamination of Non-Sterile Products: The products have been found to contain yeast/mold and microbial contamination identified as Achromobacter.

What You Should Do

Consumers and healthcare providers should stop using this product immediately. Contact Medinatura New Mexico, inc. or your healthcare provider for guidance. Notification method: Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit

About This Product

ReBoost Nasal Spray is marketed as a health product for nasal congestion relief. Consumers typically purchase it for its intended use in alleviating symptoms of colds and allergies.

Why This Is Dangerous

The contamination with Achromobacter poses a risk of infection, particularly for those with weakened immune systems. The presence of yeast and mold can exacerbate respiratory issues.

Industry Context

This recall is not part of a broader industry pattern.

Real-World Impact

Consumers are urged to stop using the product immediately, which may cause inconvenience for those relying on it for symptom relief.

Practical Guidance

How to identify if yours is affected

  1. Check for the UPC code 787647101863 on your ReBoost Nasal Spray bottle.
  2. Verify that the product is within the expiration date.
  3. Contact MediNatura if you are unsure about your product's status.

Where to find product info

The UPC code can typically be found on the packaging label of the nasal spray bottle.

What timeline to expect

Expect a refund or replacement processing timeline of approximately 4-6 weeks.

If the manufacturer is unresponsive

  • Document your communication attempts with MediNatura.
  • Consider reaching out to the FDA for assistance in unresolved complaints.
  • Keep copies of any correspondence sent to the company.

How to prevent similar issues

  • Look for nasal sprays that are certified sterile or have undergone rigorous quality testing.
  • Check for recalls before purchasing health products.
  • Consult a healthcare provider for recommendations on safe nasal sprays.

Documentation advice

Keep a copy of your purchase receipt and any correspondence with MediNatura regarding the recall.

Get instant alerts for Health & Personal Care recalls

Be the first to know. Free instant alerts to your inbox.

No spamUnsubscribe anytime

Product Details

ReBoost Nasal Spray, 0.68 fl. oz. (20 mL) bottles, distributed by MediNatura. NDC 62795-4005-9, UPC 787647101863. Sold nationwide in the US.

Key Facts

  • Recall date: December 12, 2025
  • Report date: January 14, 2026
  • Class I recall due to serious health risks
  • Microbial contamination identified as Achromobacter
  • Distributed nationwide in the US

Safety Guide

Not sure what to do next? Our guide walks you through the process step by step.

Read: What to Do When You Find a Recalled Product

Get Alerts for Health & Personal Care Recalls

Get instant alerts for recalls that affect you. Free forever.

Safety Assessment

Risk LevelHIGH
Severity Score
8/ 10
Affected Groups
GENERAL
Injury Types
OTHER

Product Classification

Product Details

Model Numbers
All lots within expiry.
UPC Codes
62795-4005
62795-4005-9
7876471018
Affected States
ALL
Report Date
January 14, 2026
Source Agency
FDA - Drug Safety
Recall Status
ACTIVE

Related Recalls

Health & Personal Care
MEDIUM

Taro Pharmaceuticals Withdraws Diclofenac Sodium Gel Over Viscosity Issues

Taro Pharmaceuticals announced a market withdrawal of Diclofenac Sodium, Topical Gel, 3% on January 27, 2026. The withdrawal stems from out of specification viscosity results. Healthcare providers and consumers should stop using the product immediately.

BEEKEEPER'S NATURALS USA
Microbial Contamination
Read more
Health & Personal Care
MEDIUM

AvKARE Recalls Rosuvastatin Tablets Due to Dissolution Issues

AvKARE recalled 7,991 cartons of Rosuvastatin Tablets on December 31, 2025. The recall stems from the product being out of specification for dissolution. Consumers should stop using the medication immediately and consult healthcare providers for guidance.

SUN PHARMACEUTICAL INDUSTRIES
Labeling: Not
Read more